İLHAN, O. Et Al. 2020. Ibrutinib As a Promising Treatment for Pulmonary Complications Due to Refractory Chronic Graft Versus Host Disease. Transplantation and Cellular Therapy (TCT) Meetings of ASTCT and CIBMTR , (Florida, United States Of America).

İLHAN, O., Seval, G. C., Uzay, A., KAYA, E., Ozturk, Z. N., Deveci, B., ... YAVAŞOĞLU, İ.(2020). Ibrutinib As a Promising Treatment for Pulmonary Complications Due to Refractory Chronic Graft Versus Host Disease . Transplantation and Cellular Therapy (TCT) Meetings of ASTCT and CIBMTR, Florida, United States Of America

İLHAN, OSMAN Et Al. "Ibrutinib As a Promising Treatment for Pulmonary Complications Due to Refractory Chronic Graft Versus Host Disease," Transplantation and Cellular Therapy (TCT) Meetings of ASTCT and CIBMTR, Florida, United States Of America, 2020

İLHAN, OSMAN Et Al. "Ibrutinib As a Promising Treatment for Pulmonary Complications Due to Refractory Chronic Graft Versus Host Disease." Transplantation and Cellular Therapy (TCT) Meetings of ASTCT and CIBMTR , Florida, United States Of America, 2020

İLHAN, O. Et Al. (2020) . "Ibrutinib As a Promising Treatment for Pulmonary Complications Due to Refractory Chronic Graft Versus Host Disease." Transplantation and Cellular Therapy (TCT) Meetings of ASTCT and CIBMTR , Florida, United States Of America.

@conferencepaper{conferencepaper, author={OSMAN İLHAN Et Al. }, title={Ibrutinib As a Promising Treatment for Pulmonary Complications Due to Refractory Chronic Graft Versus Host Disease}, congress name={Transplantation and Cellular Therapy (TCT) Meetings of ASTCT and CIBMTR}, city={Florida}, country={United States Of America}, year={2020}}